Apixaban Looks Better than Dual Antiplatelet Tx in Afib

ACC 2011 — NEW ORLEANS -- The investigational oral Factor Xa inhibitor apixaban appears to prevent brain attacks without a risk of excessive bleeding, according to results from clinical trials that were presented here by Dutch researchers.

Keywords: ACC Annual Scientific Session


< Back to Listings